Abstract

DIAZ-GAGO, A; VELEZ-DIAZ-PALLARES, M; MIHAELA-PIRLITU, A  and  ALVAREZ-DIAZ, A. Heart disorders in the context of hydroxychloroquine treatment for SARS-Cov2: a case report. Rev. OFIL·ILAPHAR [online]. 2020, vol.30, n.4, pp.337-338.  Epub May 25, 2021. ISSN 1699-714X.  https://dx.doi.org/10.4321/s1699-714x2020000400013.

We present the clinical case of a healthcare professional who has suffered a probable adverse reaction by hydroxychloroquine in the targeted treatment for SARS-Cov2. The patient was treated with hydroxychloroquine, azithromycin, and cefditoren, and after completing the treatment, she had cardiovascular disorders such as heart failure and tachycardia. At present, the benefit-risk balance appears to be unfavorable to the use of hydroxychloroquine in the treatment of SARS-Cov2 disease.

Keywords : Hidroxicloroquine; adverse drug events; COVID-19.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )